Facial flushing after thermocoagulation of the Gasserian ganglion
- PMID: 6604132
- PMCID: PMC1027478
- DOI: 10.1136/jnnp.46.7.611
Facial flushing after thermocoagulation of the Gasserian ganglion
Abstract
The development of a facial flush during thermocoagulation of the Gasserian ganglion was monitored in 16 patients with pulse recording techniques and in a further 17 patients with thermography. There was a close association between the development of the facial flush in the distribution of one or more divisions of the trigeminal nerve and the subsequent demonstration of postoperative analgesia. In regions where significant changes took place, vascular pulsations increased 25-233% (mean 96%) and facial temperature rose 0.5-2.0 degrees C. The response persisted for up to an hour postoperatively, and was not diminished in patients with pre-operative analgesia from a previous procedure. Possible mechanisms for the facial flush, including stimulation of an active vasodilator system, the antidromic release of vasoactive substances from trigeminal nerve terminals and the release of tonic vasoconstriction are discussed. A practical application of the pulse recording technique used in the present investigation would be to monitor the distribution of vasodilatation at operation to avoid unwanted first division sensory loss.
Similar articles
-
500 Percutaneous thermocoagulations of the Gasserian ganglion for trigeminal pain.Surg Neurol. 1977 Aug;8(2):126-31. Surg Neurol. 1977. PMID: 302039
-
[Parameters of high-frequency thermocoagulation of the Gasserian ganglion in the treatment of trigeminal neuralgia in order to obtain analgesia without anesthesia].Neurochirurgie. 1983;29(3):191-5. Neurochirurgie. 1983. PMID: 6604238 French.
-
[Percutaneous Gasserian ganglion thermocoagulation].No Shinkei Geka. 1982 Sep;10(9):923-30. No Shinkei Geka. 1982. PMID: 6983660 Japanese. No abstract available.
-
Radiofrequency thermoablation of the peripheral branches of trigeminal nerve versus the Gasserian ganglion for treating idiopathic trigeminal neuralgia: A systematic review and meta-analysis.J Clin Neurosci. 2022 Oct;104:42-47. doi: 10.1016/j.jocn.2022.08.005. Epub 2022 Aug 11. J Clin Neurosci. 2022. PMID: 35963063
-
[The current treatment of trigeminal neuralgia. Experience in 162 thermorhizotomies].Schweiz Rundsch Med Prax. 1992 Dec 22;81(52):1565-73. Schweiz Rundsch Med Prax. 1992. PMID: 1475559 Review. German.
Cited by
-
Relationship Between Dermoscopic Capillary-Related Features of the Auricle and Earlobe and Rosacea Subtype and Disease Severity: A Cross-Sectional Analysis.Clin Cosmet Investig Dermatol. 2023 Nov 9;16:3221-3228. doi: 10.2147/CCID.S436368. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37965100 Free PMC article.
-
Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.J Headache Pain. 2009 Jun;10(3):137-43. doi: 10.1007/s10194-009-0112-8. Epub 2009 Mar 28. J Headache Pain. 2009. PMID: 19330286 Free PMC article. Review.
-
Sweating and vascular responses in the face: normal regulation and dysfunction in migraine, cluster headache and harlequin syndrome.Clin Auton Res. 1994 Oct;4(5):273-85. doi: 10.1007/BF01827433. Clin Auton Res. 1994. PMID: 7888747 Review.
-
Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.Br J Pharmacol. 1991 Jun;103(2):1421-8. doi: 10.1111/j.1476-5381.1991.tb09805.x. Br J Pharmacol. 1991. PMID: 1653072 Free PMC article.
-
Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.Drugs. 2005;65(18):2557-67. doi: 10.2165/00003495-200565180-00002. Drugs. 2005. PMID: 16392873 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources